Skip to main content
letter
. 2020 Apr 9;45(4):323–324. doi: 10.1007/s00059-020-04920-4

Fig. 1.

Fig. 1

Overview of the possible interaction between the renin–angiotensin–aldosterone system, antihypertensive medication, and COVID-19. For details, see text. ACE2 angiotensin-converting enzyme 2, ACEI angiotensin-converting enzyme inhibitors, ARB AT1-receptor blockers. (Contains modified image material available at Servier Medical Art under a Creative Commons Attribution 3.0 Unported License)